FORMULATION OF TETRANDRINE BEADS USING IONIC GELATION METHOD CA-PECTINATE COATED PH-SENSITIVE POLYMERS AS COLON-TARGETED DOSAGE FORM

Raditya Iswandana; Kurnia Sari Setio Putri; Cindy Espreancelly Sandiata; Sisilia Triani; Santi Purna Sari; Joshita Djajadisastra

doi:10.22159/ajpcr.2017.v10i10.19994

Authors

Raditya Iswandana Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia
Kurnia Sari Setio Putri Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia
Cindy Espreancelly Sandiata Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia
Sisilia Triani Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia
Santi Purna Sari Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia
Joshita Djajadisastra Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia

DOI:

https://doi.org/10.22159/ajpcr.2017.v10i10.19994

Keywords:

Beads, Tetrandrine, Calcium pectinate, Ionic gelation, Colon-targeted

Abstract

Objectives Pectin, a natural polysaccharide, can be used as colon targeted drug delivery systems. Ionotropic gelation of pectin in the presence of certain divalent cations, such as calcium ions, protects drugs by producing insoluble hydrogels that can be used as a colon-targeted drug delivery carrier. In this study, calcium pectinate beads containing tetrandrine were made and were evaluated for in-vitro drug release and in-vivo study.

Methods: Calcium pectinate beads were prepared by ionic gelation method with varied calcium chloride concentration (5%, 10%, and 15%). The best formula was coated with pH sensitive polymers, i.e. Eudragit L100-55, Eudragit L100, HPMCP (Hydroxypropylmethyl Cellulose Phthalate) HP-55 or CAP (Cellulose Acetate Phthalate).

Results: Characterization results showed that the beads produced were quite spherical and have yellow-brownish color. After the coating process, beads were used in in-vitro drug release and targeted test. From in-vitro release study, beads coated with Eudragit L100 10% has shown good colon targeted dosage form with percent cumulative release 57.87%. This result also confirmed with the in-vivo test. Beads which were coated by Eudragit L100 10% could be found in the rat intestine.

Conclusion: Formula 1 (5% calcium chloride concentration) was chosen as the best beads characterization. Formula 1C (5% beads coated with 10% Eudragit L100) showed an optimal protection from gastric acid in the in-vitro release study and able to deliver the beads to the intestine in the in-vivo targeted test.

Downloads

Download data is not yet available.

References

Sriamornsak P. Chemistry of pectin and its pharmaceutical uses: A review. Silpakorn Univ Int J 2003;3(1-2):207-28.

Philip AK, Philip B. Colon targeted drug delivery systems: A review on primary and novel approaches. Oman Med J 2010;25(2):79-87.

Das S. Targeted Delivery of Resveratrol for Colon (Doctoral Dissertation); 2009. Available from: http://www.scholarbank.nus.edu.sg/bitstream/handle/10635/16565/Das%20S.pdf.pdf?sequence=1.

Amidon S, Brown JE, Dave VS. Colon-targeted oral drug delivery systems: Design trends and approaches. AAPS PharmSciTech 2015;16(4):731-41.

Rowe R, Sheskey P, Quinn M. Handbook of pharmaceutical excipients. Handbook of Pharmaceutical Excipients. 6th ed. London: APhA/Pharmaceutical Press; 2009.

Luangmonkong T, Suriguga S, Bigaeva E, Oosterhuis D, de Jong KP, Schuppan D, et al. Antifibrotic Efficacy of a TGF-Î² Kinase Inhibitor on Early-Onset and End-Stage of Fibrosis in Precision-Cut Human Liver Slices; AASLD LiverLearning; 2015:110678. Available from: https//www.liverlearning.aasld.org/aasld/2015/thelivermeeting/110678/theerut.luangmonkong.antifibrotic.efficacy.of.a.tgf-.kinase.inhibitor.on.html.

Iswandana R, Pham BT, van Haaften WT, Luangmonkong T, Oosterhuis D, Mutsaers HA, et al. Organ- and species-specific biological activity of rosmarinic acid. Toxicol In Vitro 2016;32:261-8.

Westra IM, Oosterhuis D, Groothuis GM, Olinga P. Precision-cut liver slices as a model for the early onset of liver fibrosis to test anti-fibrotic drugs. Toxicol Appl Pharmacol 2014;274(2):328-38.

Latella G, Sferra R, Speca S, Vetuschi A, Gaudio E. Can we prevent, reduce or reverse intestinal fibrosis in IBD? Eur Rev Med Pharmacol Sci 2013;17(10):1283-304.

Snejdrova E, Dittrich M. Pharmaceutical applications of plasticized polymers. In: Recent Advances in Plasticizers. Croatia: InTech; 2012. p. 69-90.

Prajapati SK, Tripathi P, Ubaidulla U, Anand V. Design and development of gliclazide mucoadhesive microcapsules: In vitro and in vivo evaluation. AAPS PharmSciTech 2008;9(1):224-30.

Tripathi GK, Singh S. Formulation and in vitro evaluation of pH-sensitive oil-entrapped buoyant beads of clarithromycin. Trop J Pharm Res 2010;9(6):533-9.

Mohanty S, Panigrahi AK. Multiparticulate drug delivery system for colon targeting. Int J Pharm Pharm Sci 2015;7(3):433-6.

El-Menshawe SF, Abdeltwab AM, Mohamed AI. Novel gastro-retentive polymeric microspheres: An approach for increased bioavailability and an once daily dosing of terbutaline sulfate. Int J Pharm Pharm Sci 2016;8(8):320-9.

McCarry P. Investigation into the Production of Calcium Pectinate Particles for Oral Delivery to the Colon (Master Dissertation); 2011. Available from: http://www.etheses.bham.ac.uk/2879/1/McCarry_11_Mres.pdf.

VdoviakovÃ¡ K, PetrovovÃ¡ E, MaloveskÃ¡ M, KreÅ¡Ã¡kovÃ¡ L, Teleky J, Elias MZ, et al. Surgical anatomy of the gastrointestinal tract and its vasculature in the laboratory rat. Gastroenterol Res Pract 2016.